Old Web
English
Sign In
Acemap
>
authorDetail
>
Linda S. Appiah-Kubi
Linda S. Appiah-Kubi
St Thomas' Hospital
Cabergoline
Medicine
Parkinson's disease
Dopamine agonist
Tolerability
4
Papers
14
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Use and tolerability of cabergoline in young and older people with Parkinson’s disease: a multi center observational study
2003
Alison Forbes
Una Brechany
Frauke Stegie
Andrea Stutt
K. Ray Chaudhuri
Linda S. Appiah-Kubi
Angus Nisbet
David J. Burn
Kallol Ray Chaudhuri
Show All
Source
Cite
Save
Citations (2)
Cabergoline monotherapy in clinical practice: A two year observational study of tolerability and efficacy in young, old and very elderly patients with Parkinson's disease
2002
Journal of Neurology, Neurosurgery, and Psychiatry
Linda S. Appiah-Kubi
Angus Nisbet
David J. Burn
CK Ray
Show All
Source
Cite
Save
Citations (0)
Use of the dopamine agonist cabergoline in the treatment of movement disorders.
2002
Expert Opinion on Pharmacotherapy
Aimee Di Marco
Linda S. Appiah-Kubi
K. Ray Chaudhuri
Show All
Source
Cite
Save
Citations (12)
1